Journal List > Allergy Asthma Respir Dis > v.7(3) > 1130421

Kim and Yoon: Tracheostomy in children: A 9-year experience in a tertiary hospital in Korea

Abstract

Purpose

Tracheostomy has been increasingly performed in children, along with the improvements in neonatal and pediatric intensive care. The objective of this study was to describe the indications, comorbidities, complications, and outcomes of tracheostomy in children in a tertiary hospital.

Methods

This was a retrospective study of children who required tracheostomy in a tertiary hospital in Korea between April 2009 and March 2018. The medical records of the patients were retrospectively reviewed and analyzed.

Results

A total of 41 children underwent tracheostomy. The median age of the patients was 11.9 months (interquartile range [IQR], 5.4–179.2 months), and 20 (48.8%) were boys. Tracheostomy was performed commonly in respiratory disease (12 [29.2%]) and neurologic disease (17 [41.5%]). The indications of tracheostomy differed according to patient age. There were trends toward longer length of intubation (median, 78.0 days; IQR, 36.0–185.0 days), longer hospitalization (213.3±154.5 days), higher decannulation rate (32.0%) and lower complications (12.0%) in patients who received tracheostomy as an infant/toddler.

Conclusion

Regarding pediatric tracheostomy in this study, there were bimodal age distribution and consequential clinical differences depending on patient age.

References

1. Deutsch ES. Tracheostomy: pediatric considerations. Respir Care. 2010; 55:1082–90.
2. Watters KF. Tracheostomy in infants and children. Respir Care. 2017; 62:799–825.
crossref
3. Kremer B, Botos-Kremer AI, Eckel HE, Schlöndorff G. Indications, complications, and surgical techniques for pediatric tracheostomies–an update. J Pediatr Surg. 2002; 37:1556–62.
crossref
4. Pereira KD, MacGregor AR, Mitchell RB. Complications of neonatal tracheostomy: a 5-year review. Otolaryngol Head Neck Surg. 2004; 131:810–3.
crossref
5. Carron JD, Derkay CS, Strope GL, Nosonchuk JE, Darrow DH. Pediatric tracheotomies: changing indications and outcomes. Laryngoscope. 2000; 110:1099–104.
crossref
6. Berry JG, Graham DA, Graham RJ, Zhou J, Putney HL, O'Brien JE, et al. Predictors of clinical outcomes and hospital resource use of children after tracheotomy. Pediatrics. 2009; 124:563–72.
crossref
7. Parrilla C, Scarano E, Guidi ML, Galli J, Paludetti G. Current trends in paediatric tracheostomies. Int J Pediatr Otorhinolaryngol. 2007; 71:1563–7.
crossref
8. Suh J, Lee JH, Chung MK, Jeong HS, Son YI, Ahn K, et al. Causes and outcome of tracheostomy in children. Pediatr Allergy Respir Dis. 2012; 22:188–96.
crossref
9. Lewis CW, Carron JD, Perkins JA, Sie KC, Feudtner C. Tracheotomy in pediatric patients: a national perspective. Arch Otolaryngol Head Neck Surg. 2003; 129:523–9.
10. Funamura JL, Durbin-Johnson B, Tollefson TT, Harrison J, Senders CW. Pediatric tracheotomy: indications and decannulation outcomes. Laryngoscope. 2014; 124:1952–8.
crossref
11. Lee JH, Smith PB, Quek MB, Laughon MM, Clark RH, Hornik CP. Risk factors and in-hospital outcomes following tracheostomy in infants. J Pediatr. 2016; 173:39–44.e1.
crossref
12. Wakeham MK, Kuhn EM, Lee KJ, McCrory MC, Scanlon MC. Use of tracheostomy in the PICU among patients requiring prolonged mechanical ventilation. Intensive Care Med. 2014; 40:863–70.
crossref
13. McPherson ML, Shekerdemian L, Goldsworthy M, Minard CG, Nelson CS, Stein F, et al. A decade of pediatric tracheostomies: Indications, outcomes, and longterm prognosis. Pediatr Pulmonol. 2017; 52:946–53.
crossref
14. Tsuboi N, Ide K, Nishimura N, Nakagawa S, Morimoto N. Pediatric tracheostomy: survival and longterm outcomes. Int J Pediatr Otorhinolaryngol. 2016; 89:81–5.
crossref
15. Mahida JB, Asti L, Boss EF, Shah RK, Deans KJ, Minneci PC, et al. Tracheostomy placement in children younger than 2 years: 30-day outcomes using the national surgical quality improvement program pediatric. JAMA Otolaryngol Head Neck Surg. 2016; 142:241–6.
16. Schweiger C, Manica D, Becker CF, Abreu LS, Manzini M, Sekine L, et al. Tracheostomy in children: a ten-year experience from a tertiary center in southern Brazil. Braz J Otorhinolaryngol. 2017; 83:627–32.
crossref
17. Watters K, O'Neill M, Zhu H, Graham RJ, Hall M, Berry J. Two-year mortality, complications, and healthcare use in children with medicaid following tracheostomy. Laryngoscope. 2016; 126:2611–7.
crossref
18. Freeman BD, Morris PE. Tracheostomy practice in adults with acute respiratory failure. Crit Care Med. 2012; 40:2890–6.
crossref
19. Brass P, Hellmich M, Ladra A, Ladra J, Wrzosek A. Percutaneous techniques versus surgical techniques for tracheostomy. Cochrane Database Syst Rev. 2016; 7:CD008045.
crossref

Fig. 1.
There were bimodal age distribution depending on the age of tracheostomy.
aard-7-137f1.tif
Table 1.
Demographics of subjects (n=41)
Variable Value
Male sex 20 (48.8)
Age at tracheostomy (mo) 11.9 (5.4–179.2)
Preterm birth 15 (36.6)
Length of intubation before tracheostomy (day) 26 (13–102)
Length of hospitalization (day) 90 (53–229)

Values are presented as number (%) or median (interquartile range).

Table 2.
Indications for tracheostomy
Indication No. of patients (%)
Airway obstruction 6 (14.6)
Subglottic stenosis 1 (2.4)
Laryngomalacia 4 (9.8)
Others* 1 (2.4)
Respiratory disease 12 (29.2)
Bronchopulmonary dysplasia 6 (14.6)
Chronic respiratory failure 6 (14.6)
Neurologic disease 17 (41.5)
Hypoxic ischemic enphalopathy 5 (12.2)
Intractable epilepsy 3 (7.3)
Traumatic brain injury 6 (14.6)
Others 3 (7.3)
Congenital muscular disease 3 (7.3)
Craniofacial anomaly 3 (7.3)

* Others: tension pneumothorax.

Others: cerebral palsy, meningoencephalitis, brain tumor.

Table 3.
Comorbidities in the patients
Comorbidities No. of patients (%)
Congenital heart disease 12 (33.3)
Bronchopulmonary dysplasia 6 (16.7)
Neurologic disease 6 (16.7)
Gastrointestinal disease 2 (5.5)
Genetic disorder 6 (16.7)
Cancer 3 (8.3)
Others* 1 (2.8)

* Others: relapsing polychondritis.

Table 4.
Clinical characteristics of the patients
Variable Infant/toddler (n=25) Adolescent (n=16) P-value
Male sex 13 (52.0) 7 (43.8) 0.85
Age at tracheostomy (mo) 6.5 (2.6–9.2) 184.5 (175.2–200.6) 0.00
Length of intubation (day) 78.0 (36.0–185.0) 13.5 (7.0–17.0) 0.00
Indications for tracheostomy      
Respiratory disease 10 (40.0) 2 (12.5)  
Neurologic disease 7 (28.0) 10 (62.5)  
Airway obstruction 3 (12.0) 3 (18.8)  
Craniofacial anomaly 2 (8.0) 1 (6.2)  
Congenital muscular disease 3 (12.0) 0 (0.0)  
Length of MV (day) 107.0 (67.0–232.0) 17.0 (4.5–25.0) 0.00
Length of hospitalization (day) 213.3±154.5 74.6±65.0 0.00
Successful decannulation 8 (32.0) 3 (18.8) 0.57
Complications 3 (12.0) 6 (37.5) 0.12

Values are presented as number (%), median (interquartile range), or mean±standard deviation.

MV, mechanical ventilation.

Table 5.
Patients with successful decannulation after tracheostomy
Patient No. GA (wk) Tr Age at racheostom (mo) Indications of tracheostomy Duration of intubation (day) Duration of tracheostomy (day)
1 32 6.5 HIE 196 320
2 33 8.8 BPD 264 44
3 35 7.0 BPD 211 256
4 26 11.9 BPD 356 165
5 28 9.6 BPD 287 357
6 27 7.5 BPD 226 176
7 38 1.9 Velopharyngeal insufficiency 20 867
8 37 2.6 BPD 78 2,084
9 Full term 204.3 SAH 10 51
10 Full term 199.1 SAH 13 38
11 Full term 215.7 Airway problem 16 106

GA, gestational age; HIE, hypoxic ischemic encephalopathy; BPD, bronchopulmonary dysplasia; SAH, subarachnoid hemorrhage.

TOOLS
Similar articles